Last updated on 12 Feb, 2026 | 23:16 IST
Rights Ratio | Face Value  | Premium | Ex-Right Date | Record Date  | Announcement Date |
|---|---|---|---|---|---|
| No data found | |||||
*Disclaimer: The information listed is solely for research purposes and are not recommendations. Please conduct your own research before making any investment decisions.
Existing shareholders of Eris Lifesciences as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.
Shareholders can apply for Eris Lifesciences rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.
No! Participation in Eris Lifesciences rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.
No, Eris Lifesciences hasn’t had any right issues as of {{current_date}} in last 2023-2025
No, Eris Lifesciences hasn’t had any right issues as of {{current_date}} in last 2023-2025